Stocks and Investing Stocks and Investing
Tue, September 13, 2011

NDAQ, BABY, HDB, KRO, ANGO, BDC Are Seasonally Ripe To Go Up In the Next Five Weeks


Published on 2011-09-13 07:40:41 - WOPRAI
  Print publication without navigation


September 13, 2011 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of NASDAQ OMX GROUP/THE (NASDAQ:NDAQ), NATUS MEDICAL INC (NASDAQ:BABY), HDFC BANK LTD-ADR (NYSE:HDB), KRONOS WORLDWIDE INC (NYSE:KRO), ANGIODYNAMICS INC (NASDAQ:ANGO), BELDEN INC (NYSE:BDC) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at: http://www.squeezetrigger.com/services/strat/mh.php

The following stocks are expected to go Up:

     Symbol     Company                             Expected Return     Odds                    By The Following Date
     NDAQ       NASDAQ OMX GROUP/THE                4.37%               88.89% (8 of 9)         Monday, September 26th 2011
     BABY       NATUS MEDICAL INC                   5.26%               100.00% (9 of 9)        Monday, September 19th 2011
     HDB        HDFC BANK LTD-ADR                   5.23%               88.89% (8 of 9)         Tuesday, September 20th 2011
     KRO        KRONOS WORLDWIDE INC                7.88%               85.71% (6 of 7)         Thursday, September 29th 2011
     ANGO       ANGIODYNAMICS INC                   5.66%               85.71% (6 of 7)         Monday, September 19th 2011
     BDC        BELDEN INC                          5.01%               85.71% (6 of 7)         Tuesday, September 20th 2011
NASDAQ OMX GROUP/THE (NASDAQ:NDAQ) - The NASDAQ OMX Group, Inc. provides trading, exchange technology, securities listing, and public company services worldwide. It offers trading across various asset classes, including equities, derivatives, debt, commodities, structured products, and exchange traded funds; capital formation solutions; financial services and exchanges technology; market data products; and financial indexes. The company also provides broker services comprising technology and customized securities administration solutions, such as back-office systems to financial participants. As of December 31, 2009, a total of 2,852 companies listed securities on The NASDAQ Stock Market representing various industries, including telecommunication services and information technology, financial services, healthcare, consumer products, industrials, and energy, as well as funds or governments. The NASDAQ OMX Group supports the operations of approximately 70 exchanges, clearing organizations, and central securities depositories. The company was formerly known as The Nasdaq Stock Market, Inc. and changed its name to The NASDAQ OMX Group, Inc. in February 2008. The NASDAQ OMX Group, Inc. was founded in 1971 and is based in New York, New York.

NATUS MEDICAL INC (NASDAQ:BABY) - Natus Medical Incorporated develops, manufactures, and markets neurodiagnostic and newborn care products worldwide. It provides healthcare products used for the screening, detection, treatment, monitoring, and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and balance and mobility disorders. The companys product offerings include neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology, as well as newborn care products, such as hearing screening systems and phototherapy devices for the treatment of jaundice in newborn; head-cooling products for the treatment of brain injury in newborns; and software systems for managing and tracking disorders and diseases. The companys newborn hearing screening products consist of the ALGO, ABaer, AuDX, and Echo-Screen newborn hearing screeners, as well as hearing screening supply products that are used with newborn hearing screening devices; diagnostic hearing assessment products comprise the Navigator Pro system, the Scout Sport diagnostic device, the HINT PRO, the AuDX PRO, and the Cochlea-Scan to identify abnormalities affecting the peripheral and central auditory nervous systems; and diagnostic hearing supply products. Natus Medical also offers monitoring systems, balance and mobility products, and jaundice management products. In addition, the company offers medical devices, including photometers, radiometers, patient warming lamps, neonatal heatshields, pediatric scales, blanket warming cabinets, exam lights, oxygen hoods, and newborn circumstraints; disposable supplies, which include neonatal noise attenuators, phototherapy eye masks, restraining boards, and x-ray shields; and newborn screening data management products. It serves hospitals, clinics, laboratories, physicians, nurses, audiologists, and governmental agencies. The company was founded in 1987 and is headquartered in San Carlos, California.

HDFC BANK LTD-ADR (NYSE:HDB) - HDFC Bank Limited provides commercial banking products and services in India. It operates in three segments: Retail Banking, Wholesale Banking, and Treasury. The Retail Banking segment offers various deposit products, including savings accounts, current accounts, fixed deposits, recurring deposits, and demat accounts. It also provides auto, personal, commercial vehicle, home, gold, and educational loans; loans against gold, securities, property, and rental receivables; and health care finance, retail agri and tractor loans, working capital finance, construction equipment finance, and warehouse receipt loans, as well as credit cards, debit cards, depository, investment advisory, bill payments, and transactional services; and distributes life, health, and general insurance, and mutual fund products. In addition, this segment offers wealth advisory, tax planning, bonds, forex and trade services, and private banking services. The Wholesale Banking segment provides loans, non-fund facilities, and transaction services to large corporate, emerging corporate, small and medium enterprise, public sector units, government bodies, financial institutions, and medium scale enterprises. It offers commercial and transactional banking services, including working capital finance, trade services, transactional services, cash management, and structured solutions to corporate customers, mutual funds, stock exchange members, and banks. The Treasury segment offers products in the areas of foreign exchange and derivatives, money market and debt securities, and equities. The company also offers NRI banking services. As of March 31, 2010, it operated a network of 1,725 branches in 779 cities, as well as 4,232 automated teller machines. The company was founded in 1994 and is based in Mumbai, India.

KRONOS WORLDWIDE INC (NYSE:KRO) - Kronos Worldwide, Inc. engages in the production and marketing of titanium dioxide pigments in North America and Europe. The titanium dioxide pigments are used to impart whiteness, brightness, and opacity for products, such as coatings, plastics, papers, fibers, food, ceramics, and cosmetics. The company produces titanium dioxide pigments in two crystalline forms, such as rutile and anatase under the Kronos brand name. It also offers ilmenite, a raw material used directly as a feedstock; and iron-based chemicals, which are co-products and processed co-products of the titanium dioxide pigment production process and used as treatment and conditioning agents for industrial effluents and municipal wastewater, as well as in the manufacture of iron pigments, cement, and agricultural products. In addition, the company provides titanium oxychloride and titanyl sulfate, which are side-stream products from the production of titanium dioxide pigments and used in specialty applications in the formulation of pearlescent pigments; production of electroceramic capacitors for cell phones and other electronic devices; and pearlescent pigments, natural gas pipe, and other specialty applications. It primarily serves paint, plastics, and paper manufacturers. The company was founded in 1989 and is headquartered in Dallas, Texas. Kronos Worldwide, Inc. is a subsidiary of Valhi, Inc.

ANGIODYNAMICS INC (NASDAQ:ANGO) - AngioDynamics, Inc. designs, develops, manufactures, and markets various therapeutic and diagnostic devices that enable interventional physicians to treat peripheral vascular disease, tumors, and other non-coronary diseases. It operates in three segments: Peripheral Vascular, Access, and Oncology/Surgery. The Peripheral Vascular segment offers and manages venous, angiographic, percutaneous transluminal angioplasty (PTA), drainage, thrombolytic, targeted renal therapy, micro access, and transjugular access product lines. Its venous products include VenaCure and Sotradecol products; angiographic product line comprises angiographic catheters, entry needles, guidewires, and fluid management products; PTA product line consists of PTA dilation balloon catheters, including WORKHORSE and PROFILER to open blocked blood vessels and dialysis access sites; drainage product line includes TOTAL ABSCESSION general drainage catheters; and thrombolytic product line comprises PULSE SPRAY, UNI FUSE, and SPEEDLYSER catheters. The Access segment provides and manages dialysis, port, and PICC product lines. Its dialysis product line includes dialysis catheters, which are marketed under the DuraMax, SCHON, EVENMORE, DURA-FLOW, SCHON XL, and LIFEJET F-16 brands. The Oncology/Surgery segment offers radio frequency ablation products, which include radiofrequency ablation (RFA) disposable electrodes, RF resection device, and RFA generators; embolization products; and NanoKnife products, based on the principles of Irreversible Electroporation. The company offers its products to interventional radiologists, vascular surgeons, and surgical oncologists through a direct sales force in the United States and through a combination of direct sales and distributor relationships internationally. AngioDynamics, Inc. was founded in 1988 and is headquartered in Queensbury, New York.

BELDEN INC (NYSE:BDC) - Belden Inc. designs, manufactures, and markets cable, connectivity, and networking products in various markets, including industrial automation, enterprise, transportation, infrastructure, and consumer electronics. The companys cable products include copper cables comprising shielded and unshielded twisted pair cables, coaxial cables, and stranded cables; fiber optic cables that transmit light signals through glass or plastic fibers; and composite cables, which are combinations of multi conductor, coaxial, and fiber optic cables jacketed together or otherwise joined together to serve complex applications and provide ease of installation. It also produces and sells connectors primarily for industrial and data networking applications, as well as sells end-to-end structured cabling solutions. In addition, the companys active connectivity products include industrial ethernet switches and related equipment, fiber optic interfaces and media converters used to bridge fieldbus networks over long distances, and load-moment indicators for mobile cranes and other load-bearing equipment. Further, its wireless products consist of a range of wireless local area network products for use in various markets, including the healthcare, education, and enterprise markets. The company sells its products directly to original equipment manufacturers, and installers of equipment and systems, as well as to distributors. Belden sells industrial products primarily through value-added resellers, industrial distributors, and original equipment manufacturers. It primarily operates in the United States, Canada, Europe, Latin America, Africa, the Asia Pacific, and the Middle East. The company was founded in 1993 and is based in St. Louis, Missouri.

SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com

www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.

INVESTMENTS & TRADING

SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

About SQUEEZETRIGGER.COM

WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.

SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.

Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.

By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.

Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641

Contributing Sources